The longest lived people among us, called "supercentenarians," have an abundance of cancer-killing immune cells, study finds.
Learn more in Cell Reports: https://t.co/iFKWukx2c7
Kosuke Hashimoto, Nobuyoshi Hirose, Piero Carninci, Yasumichi Arai, & colleagues
@cellreports
Today is World Press Freedom Day! #ProtectJournalists 📰
On this day, we support initiatives that empower journalists to explore complex issues in depth.
Interested in applying for a journalism residency? Apply by 6 May.
👉 https://t.co/iclLEzsKVb
L’endometriosi non è un’esagerazione, è una malattia cronica che merita attenzione, ascolto e diagnosi tempestive. Nel nostro Paese colpisce circa 3 milioni di donne, ma troppo spesso viene ignorata o sottovalutata.
Facciamo luce sull’endometriosi 💜
Can combined CTC detection and multi-omics approaches move from research to real clinical application in early-stage NSCLC?
🌟Read this Commentary to open up more research ideas.
🔗Link:https://t.co/peP4CpHISm
#NSCLC#CTC#MultiOmics#PrecisionOncology#JCMT
🔥truly proud of this latest work in @GUTJournal_BMJ
💡studying the genetics of bowel habits led to the identification of vitamin B1 as a modulator of gut motility
💊potential to treat #IBS and #constipation
https://t.co/kuMAUATHK3
Exploring CTC detection in early-stage NSCLC: combining omics technologies and liquid biopsy methods may improve understanding of tumor heterogeneity and offer insights into early diagnosis and monitoring.🧬
Link:https://t.co/peP4CpHISm
#NSCLC#CTCs#LiquidBiopsy#CancerResearch
The first sleep AI foundation model for predicting diseases was published today @NatureMedicine by @james_y_zou and colleagues
https://t.co/4sITCh4K5O
With @NotebookLM I made this infographic that tells the rich story pretty well
Out today 🙌 new work from the lab in which we show that p53-driven senescence enables phospholipid headgroup recycling to help sustain the increased synthesis of membrane phospholipids of senescent cells https://t.co/SgQoQ3EMUm
Today is #WorldDiabetesDay.
#Diabetes can affect anyone, at any stage of life.
Support at home, school, work and during pregnancy makes a real difference.
Listen, learn and show up for those living with diabetes. More info 🔗https://t.co/m1Fe4a9jCm
More than 316,000 women in the US will be diagnosed with breast cancer this year. Read about prevention, screening, and treatment options during #BreastCancerAwarenessMonth: https://t.co/qgnzQiR4Bt
BIG ANNOUNCEMENT📣: I haven’t been this excited to be part of something new in 15 years… Thrilled to reveal the passion project I’ve been working on for the past year and a half!🙀🥳 It started from my frustration with the depressing effect that the current publishing system has on the well-being of myself, my team, and pretty much every scientist I know (maybe you’ve noticed from my stupid jokes… :) I was exhausted of dealing with the huge delays, reviewers that can be abusive, and how arbitrary it all is. Unfortunately, the most important factors are often WHO your reviewers are and who YOU are... It’s clear we need alternatives or at least ways to improve the situation. So, together with a really special and talented team we worked to develop this idea into “qed” a platform where you can get CONSTRUCTIVE feedback on your own work or CRITICALLY assess other people’s papers. It can be a real difference maker if many of you join us (thousands have tried it already, but today we release a NEW and much stronger version ;) Let’s harness qed to put the power back in the scientists’ hands, to do, to read & to publish science on our own terms. I’m dying for you to TRY IT, and it’s very simple - just drop a paper (the link to the website is in the replies👇) - it’s completely secure, private, and free, and you get results fast. Please show your support, SHARE, tell your friends, and let’s be the revolution 🫵!
Why do some people who have mutations of familial Alzheimer's do not get the disease?
They have protective genomic variants.
A first-rate review @TheLancetNeuro
https://t.co/v4lMiN1TZh
Targeting DNA damage in ageing: towards supercharging DNA repair https://t.co/QOJFI4lUid
This new Review discusses approaches to pharmacologically mitigate the adverse effects of DNA damage to prevent mutation-driven cancers and mitigate age-related degenerative diseases
🧵1/
🚨 Thrilled to announce the simultaneous publication of our fellowship project during #ASCO25 in #Chicago!
We analyzed 50 phase 3 cancer trials published in top journals in 2023.
👇 What we found was eye-opening. #CommonSenseOncology
Cancer of unknown primary site encompasses a heterogeneous group of metastatic cancers with an unidentified primary site of origin. Putative site-specific therapy and empirical chemotherapy are acceptable treatment options.
Read the Clinical Practice article “Cancer of Unknown Primary Site” by Kanwal Raghav, MD, from the University of Texas M.D. Anderson Cancer Center (@MDAndersonNews): https://t.co/kyFjYR8B2N
Una storia straordinaria, una grande vittoria della scienza e della medicina.
Guardate bene questo bimbo, di cui si conoscono solo le iniziali, KJ.
KJ, nato con una rarissima malattia genetica letale (deficit di CPS1), è il primo paziente al mondo
1/